000			01502nam a2200253 4500
001			384316
010			_a929168063X
090			_a384316
100			_a20070531d1999 y0pory50 ba
101			_aeng
200			_aReport on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA
210			_aLuxembourg _cOffice for Official Publications of the European Communities _d1999
215			_a94 p. _d21 cm
330			_aForeword. Abbreviations. Introduction. Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Joint action concerning the information exchange, risk assessment and the control of new synthetic drugs. EMCDDA-EDU progress report on the joint action on new synthetic drugs. The pharmacotoxicology and neuropsychology of N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB). Sociological and criminological evidence on the risks of MBDB. Public health risks of MBDB: epidemiological evidence. References. Participants in the risk-assessment process.
606			_aPREVENÇÃO DA TOXICODEPENDÊNCIA _9103892
606			_aRELATÓRIO _9410454
606			_aDROGA SINTÉTICA _9320915
606			_aCOOPERAÇÃO INTERNACIONAL _9229150
606			_aOEDT _9321506
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987
955			_xOferta